Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yimufu Yan Granules for Chronic Pelvic Pain Due to Sequelae of Pelvic Inflammatory Disease
CTR20260272Phase 2Active
- Sponsor
- Jianmin Pharmaceutical Group
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic prostatitis (CP) comparing Yimufu Yan Granules with Placebo (2 arms). Primary endpoint: Change in lower abdominal/lumbosacral pain VAS score from baseline after the 3rd treatment menstrual cycle. Started Jan 2026; status: active.
02
Drugs
Yimu Fuyan Granules
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on CTR20260272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260272.